Detalhe da pesquisa
1.
Epigenetic CRISPR Screens Identify Npm1 as a Therapeutic Vulnerability in Non-Small Cell Lung Cancer.
Cancer Res
; 80(17): 3556-3567, 2020 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32646968